6C45.4)  


methcathinone  
Stimulant withdrawal including amphetamines, methamphetamine and 
methcathinone is a clinically significant cluster of symptoms, behaviours and/or 
physiological features, varying in degree of s everity and duration, that occurs upon 
cessation or reduction of use of stimulants in individuals who have developed 
Stimulant dependence or have used stimulants for a prolonged period or in large 
amounts. Stimulant withdrawal can also occur when prescribe d stimulants have 
been used in standard therapeutic doses. Presenting features of stimulant 
withdrawal may include dysphoric mood, irritability, fatigue, insomnia or (more 
commonly) hypersomnia, vivid and unpleasant dreams, increased appetite, 
psychomotor agitation or retardation, and craving for amphetamine or related 
stimulants.  
Coding Note:  Code also the causing condition  
Exclusions:  Cocaine withdrawal (